Skip to Content
Merck
CN
All Photos(2)

Documents

Safety Information

SAB4200837

Sigma-Aldrich

Anti-DDX6 antibody, Mouse monoclonal

clone DDX6-34, purified from hybridoma cell culture

Sign Into View Organizational & Contract Pricing

Synonym(s):
ATP-dependent RNA helicase p54, DEAD box protein 6, HLR2, Oncogene RCK, Probable ATP-dependent RNA helicase DDX6
UNSPSC Code:
12352203
NACRES:
NA.41

biological source

mouse

antibody form

purified from hybridoma cell culture

antibody product type

primary antibodies

clone

DDX6-34, monoclonal

species reactivity

human, monkey, bovine, dog, rat, mouse

packaging

antibody small pack of 25 μL

concentration

~1 mg/mL

technique(s)

immunoblotting: 1-2 μg/mL using human HeLa whole cell extract.
immunofluorescence: 10-20 μg/mL using human U-2-OS cells.

isotype

IgG1

UniProt accession no.

shipped in

dry ice

storage temp.

−20°C

target post-translational modification

unmodified

Gene Information

Monkey ... DDX6(101053064)
bovine ... DDX6(513906)
dog ... DDX6(479414)
human ... DDX6(1656)
mouse ... DDX6(13209)
rat ... DDX6(500988)

Related Categories

General description

Probable ATP-dependent RNA helicase DDX6 also known as DEAD box protein 6 or Oncogene RCK/p54, is a conserved member of the DEAD-box RNA helicase family. DDX6 plays a central role in P-body assembly in mammals and its depletion prevents P-body assembly leading to P-bodies disappearance.1 DDX6 coordinates RNA and ATP helicase binding activities and binds along the mRNA. DDX6 sequence specific binding at mRNA 5′ end, activates recruitment of the decapping complex, thus coupling translational repression and mRNA degradation.1-2partial human DDX6 recombinant protein 

Specificity

Monoclonal Anti-DDX6 antibody specifically recognizes DDX6 from human, mouse, monkey, canine and bovine origin.

Immunogen

partial human DDX6 recombinant protein

Application

The antibody may be used in various immunochemical techniques including Immunoblotting (~54 kDa) and Immunofluorescence. Detection of the DDX6 band by Immunoblotting is specifically inhibited by the immunogen.

Biochem/physiol Actions

DDX6 is considered to be a P-bodies marker due to its mediating role between translational repression and P-bodies formation and toits interaction with Ago2 and the RISC complex that also mediates translational silencing by miRNAs.1-4  Viruses like Hepatitis C virus (HCV) or West Nile virus (WNV) utilize the host cell DDX6 to promote virus infection by recruiting it to the viral replication sites where it is involved in stabilization of the viral genome and the shift between translation and replication.2,5-6DDX6 was reported to be overexpressed in colorectal adenocarcinomas, gastric cancer and in most malignant cell lines.7-9 It was suggested that DDX6 acted as an upstream cancerous enhancer through RNA-binding of HER2 and FGFR2 mRNAs that positively regulates post-transcriptional processes in cancer cells.7

Physical form

Supplied as a solution in 0.01 M phosphate buffered saline pH 7.4, containing 15 mM sodium azide as a preservative.

Storage and Stability

For continuous use, store at 2-8°C for up to one month. For extended storage, freeze in working aliquots. Repeated freezing and thawing is not recommended. If slight turbidity occurs upon prolonged storage, clarify the solution by centrifugation before use. Working dilution samples should be discarded if not used within 12 hours.

Disclaimer

Unless otherwise stated in our catalog our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Regulatory Information

常规特殊物品

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Aidan M Fenix et al.
Nature communications, 12(1), 6324-6324 (2021-11-05)
Mutations in the cardiac splicing factor RBM20 lead to malignant dilated cardiomyopathy (DCM). To understand the mechanism of RBM20-associated DCM, we engineered isogenic iPSCs with DCM-associated missense mutations in RBM20 as well as RBM20 knockout (KO) iPSCs. iPSC-derived engineered heart

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service